Global Gastrointestinal Therapeutics Market Size, Status and Forecast 2019-2025

SKU ID :QYR-14461967 | Published Date: 18-Jul-2019 | No. of pages: 101
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Oral 1.4.3 Parenteral 1.5 Market by Application 1.5.1 Global Gastrointestinal Therapeutics Market Share by Application (2014-2025) 1.5.2 IBD 1.5.3 Irritable Bowel Syndrome (IBS) 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Gastrointestinal Therapeutics Market Size 2.2 Gastrointestinal Therapeutics Growth Trends by Regions 2.2.1 Gastrointestinal Therapeutics Market Size by Regions (2014-2025) 2.2.2 Gastrointestinal Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Gastrointestinal Therapeutics Market Size by Manufacturers 3.1.1 Global Gastrointestinal Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Gastrointestinal Therapeutics Key Players Head office and Area Served 3.3 Key Players Gastrointestinal Therapeutics Product/Solution/Service 3.4 Date of Enter into Gastrointestinal Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Gastrointestinal Therapeutics Market Size by Type (2014-2019) 4.2 Global Gastrointestinal Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Gastrointestinal Therapeutics Market Size (2014-2019) 5.2 Gastrointestinal Therapeutics Key Players in United States 5.3 United States Gastrointestinal Therapeutics Market Size by Type 5.4 United States Gastrointestinal Therapeutics Market Size by Application 6 Europe 6.1 Europe Gastrointestinal Therapeutics Market Size (2014-2019) 6.2 Gastrointestinal Therapeutics Key Players in Europe 6.3 Europe Gastrointestinal Therapeutics Market Size by Type 6.4 Europe Gastrointestinal Therapeutics Market Size by Application 7 China 7.1 China Gastrointestinal Therapeutics Market Size (2014-2019) 7.2 Gastrointestinal Therapeutics Key Players in China 7.3 China Gastrointestinal Therapeutics Market Size by Type 7.4 China Gastrointestinal Therapeutics Market Size by Application 8 Japan 8.1 Japan Gastrointestinal Therapeutics Market Size (2014-2019) 8.2 Gastrointestinal Therapeutics Key Players in Japan 8.3 Japan Gastrointestinal Therapeutics Market Size by Type 8.4 Japan Gastrointestinal Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2014-2019) 9.2 Gastrointestinal Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type 9.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application 10 India 10.1 India Gastrointestinal Therapeutics Market Size (2014-2019) 10.2 Gastrointestinal Therapeutics Key Players in India 10.3 India Gastrointestinal Therapeutics Market Size by Type 10.4 India Gastrointestinal Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Gastrointestinal Therapeutics Market Size (2014-2019) 11.2 Gastrointestinal Therapeutics Key Players in Central & South America 11.3 Central & South America Gastrointestinal Therapeutics Market Size by Type 11.4 Central & South America Gastrointestinal Therapeutics Market Size by Application 12 International Players Profiles 12.1 AbbVie 12.1.1 AbbVie Company Details 12.1.2 Company Description and Business Overview 12.1.3 Gastrointestinal Therapeutics Introduction 12.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.1.5 AbbVie Recent Development 12.2 Allergan 12.2.1 Allergan Company Details 12.2.2 Company Description and Business Overview 12.2.3 Gastrointestinal Therapeutics Introduction 12.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.2.5 Allergan Recent Development 12.3 Johnson & Johnson 12.3.1 Johnson & Johnson Company Details 12.3.2 Company Description and Business Overview 12.3.3 Gastrointestinal Therapeutics Introduction 12.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.3.5 Johnson & Johnson Recent Development 12.4 Takeda 12.4.1 Takeda Company Details 12.4.2 Company Description and Business Overview 12.4.3 Gastrointestinal Therapeutics Introduction 12.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.4.5 Takeda Recent Development 12.5 Novartis 12.5.1 Novartis Company Details 12.5.2 Company Description and Business Overview 12.5.3 Gastrointestinal Therapeutics Introduction 12.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.5.5 Novartis Recent Development 12.6 Pfizer 12.6.1 Pfizer Company Details 12.6.2 Company Description and Business Overview 12.6.3 Gastrointestinal Therapeutics Introduction 12.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.6.5 Pfizer Recent Development 12.7 Merck 12.7.1 Merck Company Details 12.7.2 Company Description and Business Overview 12.7.3 Gastrointestinal Therapeutics Introduction 12.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.7.5 Merck Recent Development 12.8 F. Hoffmann-La Roche 12.8.1 F. Hoffmann-La Roche Company Details 12.8.2 Company Description and Business Overview 12.8.3 Gastrointestinal Therapeutics Introduction 12.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.8.5 F. Hoffmann-La Roche Recent Development 12.9 Eli Lilly 12.9.1 Eli Lilly Company Details 12.9.2 Company Description and Business Overview 12.9.3 Gastrointestinal Therapeutics Introduction 12.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.9.5 Eli Lilly Recent Development 12.10 AstraZeneca 12.10.1 AstraZeneca Company Details 12.10.2 Company Description and Business Overview 12.10.3 Gastrointestinal Therapeutics Introduction 12.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2014-2019) 12.10.5 AstraZeneca Recent Development 12.11 Procter & Gamble 12.12 Tillotts Pharma 12.13 Shire Pharmaceuticals 12.14 GlaxoSmithKline 12.15 Amgen 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
List of Tables and Figures Table Gastrointestinal Therapeutics Key Market Segments Table Key Players Gastrointestinal Therapeutics Covered Table Global Gastrointestinal Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Gastrointestinal Therapeutics Market Size Market Share by Type 2014-2025 Figure Oral Figures Table Key Players of Oral Figure Parenteral Figures Table Key Players of Parenteral Table Global Gastrointestinal Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure IBD Case Studies Figure Irritable Bowel Syndrome (IBS) Case Studies Figure Gastrointestinal Therapeutics Report Years Considered Table Global Gastrointestinal Therapeutics Market Size 2014-2025 (Million US$) Figure Global Gastrointestinal Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Gastrointestinal Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Gastrointestinal Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Gastrointestinal Therapeutics Market Share by Regions 2014-2019 Figure Global Gastrointestinal Therapeutics Market Share by Regions 2014-2019 Figure Global Gastrointestinal Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Gastrointestinal Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Gastrointestinal Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Gastrointestinal Therapeutics Market Share by Manufacturers in 2018 Table Global Gastrointestinal Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Gastrointestinal Therapeutics Product/Solution/Service Table Date of Enter into Gastrointestinal Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Gastrointestinal Therapeutics Market Size Share by Type (2014-2019) Figure Global Gastrointestinal Therapeutics Market Size Market Share by Type (2014-2019) Table Global Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Gastrointestinal Therapeutics Market Size Share by Application (2014-2019) Figure Global Gastrointestinal Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Gastrointestinal Therapeutics Revenue Market Share by Application in 2018 Figure United States Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Gastrointestinal Therapeutics Market Share (2018-2019) Table United States Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Gastrointestinal Therapeutics Market Share by Type (2014-2019) Table United States Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Gastrointestinal Therapeutics Market Share by Application (2014-2019) Figure Europe Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Gastrointestinal Therapeutics Market Share (2018-2019) Table Europe Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Gastrointestinal Therapeutics Market Share by Type (2014-2019) Table Europe Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Gastrointestinal Therapeutics Market Share by Application (2014-2019) Figure China Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Gastrointestinal Therapeutics Market Share (2018-2019) Table China Gastrointestinal Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Gastrointestinal Therapeutics Market Share by Type (2014-2019) Table China Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Gastrointestinal Therapeutics Market Share by Application (2014-2019) Figure Japan Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Gastrointestinal Therapeutics Market Share (2018-2019) Table Japan Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Gastrointestinal Therapeutics Market Share by Type (2014-2019) Table Japan Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Gastrointestinal Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Gastrointestinal Therapeutics Market Share (2018-2019) Table Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Gastrointestinal Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Gastrointestinal Therapeutics Market Share by Application (2014-2019) Figure India Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Gastrointestinal Therapeutics Market Share (2018-2019) Table India Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Gastrointestinal Therapeutics Market Share by Type (2014-2019) Table India Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Gastrointestinal Therapeutics Market Share by Application (2014-2019) Figure Central & South America Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Gastrointestinal Therapeutics Market Share (2018-2019) Table Central & South America Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Gastrointestinal Therapeutics Market Share by Type (2014-2019) Table Central & South America Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Gastrointestinal Therapeutics Market Share by Application (2014-2019) Table AbbVie Company Details Table AbbVie Revenue in Gastrointestinal Therapeutics Business (2014-2019) (Million US$) Figure AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table AbbVie Recent Development Table Allergan Company Details Table Allergan Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$) Figure Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table Allergan Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$) Figure Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table Johnson & Johnson Recent Development Table Takeda Company Details Table Takeda Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$) Figure Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table Takeda Recent Development Table Novartis Company Details Table Novartis Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table Novartis Recent Development Table Pfizer Company Details Table Pfizer Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table Pfizer Recent Development Table Merck Company Details Table Merck Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table Merck Recent Development Table F. Hoffmann-La Roche Company Details Table F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$) Figure F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table F. Hoffmann-La Roche Recent Development Table Eli Lilly Company Details Table Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$) Figure Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table Eli Lilly Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$) Figure AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019) Table AstraZeneca Recent Development Table Procter & Gamble Company Details Table Tillotts Pharma Company Details Table Shire Pharmaceuticals Company Details Table GlaxoSmithKline Company Details Table Amgen Company Details Table Global Gastrointestinal Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Gastrointestinal Therapeutics Market Size Share by Regions (2019-2025) Figure Global Gastrointestinal Therapeutics Market Size Share by Regions in 2025 Figure United States Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Gastrointestinal Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Gastrointestinal Therapeutics Market Size by Product (2019-2025) Figure Global Gastrointestinal Therapeutics Market Size by Product in 2025 Table Global Gastrointestinal Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Gastrointestinal Therapeutics Market Size by Application (2019-2025) Figure Global Gastrointestinal Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
AbbVie Allergan Johnson & Johnson Takeda Novartis Pfizer Merck F. Hoffmann-La Roche Eli Lilly AstraZeneca Procter & Gamble Tillotts Pharma Shire Pharmaceuticals GlaxoSmithKline Amgen
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients